Lucigen | LGC代理,E. cloni 10G Supreme Electrocompetent Cells, Efficiency >4 x 1010 cfu/μg,部分現(xiàn)貨

發(fā)表于由

E. cloni 10G Supreme Electrocompetent Cells, Efficiency >4 x 1010 cfu/μg

Clone, construct libraries, transform Gibson Assembly? reactions all with high-yield, T1 phage-resistant cells in high efficiencies for routine and challenging applications.

Product Details

Competent Cells include Control DNA and Recovery Medium, and are packaged as SOLOs (1 transformation per tube), DUOs (2 transformations per tube), Subcloning Grade (12 transformations per tube), or microplates as indicated. Recovery Medium is also available separately. The specified transformation efficiencies are with pUC DNA, unless indicated otherwise.

Key features

  • Direct replacements for standard cloning strains
  • Optimised genetics for high yields: phage T1 resistant, endonuclease and recombination minus, blue/white screening-capable.
  • Available in a range of transformation efficiencies .
  • Convenient packaging options.
  • High efficiency cells result in high colony counts

Select a Version

Please select a Version

Lucigen | LGC, Biosearch Technologies主要開發(fā)各類用于基因克隆的試劑盒及相關產(chǎn)品，包括：CloneSmart?平端克隆試劑盒、BigEasy?線性克隆系統(tǒng)、pEZSeq™平端克隆試劑盒、聚合酶及E.cloni?感受態(tài)細胞及蛋白表達系統(tǒng)等。

Lucigen公司憑借其獨到的產(chǎn)品技術，過硬的產(chǎn)品質(zhì)量，良好的產(chǎn)品服務贏得了全球廣大用戶的信賴。此外，Lucigen還是全球科學家青睞的Epicentre品牌產(chǎn)品的供應商。在2018年，Lucigen被LGC收購，從而加強了其在基因組市場的試劑供應。Lucigen的產(chǎn)品和服務已經(jīng)覆蓋了臨床診斷、藥物開發(fā)、合成生物學和基因編輯等多個領域。更多產(chǎn)品信息歡迎訪問Lucigen | LGC, Biosearch Technologies官網(wǎng)。